Form 4 for BWFG Bankwell Financial Group, Inc.

Accepted 2026-02-11 00:00:00 ET · period of report 2026-02-09 · accession 0001505732-26-000036 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2026-02-11	2026-02-09	BWFG	Gruseke Christopher R	CEO	A - Grant	$0.00	+9,170	177.2K	+5%	$0
	2026-02-11	2026-02-09	BWFG	Gruseke Christopher R	CEO	S - Sale	$49.79	-5,056	172.1K	-3%	-$251.7K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-02-09	A	A	7,654	$0.00	7,654	D	—	—	(F1) 7,654 shares of Bankwell Financial Group, Inc. stock granted pursuant to the 2022 Bankwell Financial Group, Inc. Stock Plan. 3,827 of those shares are restricted stock that will vest in three substantially equal annual installments, with the first installment to vest on February 7, 2027 and the second and third installments to vest on each annual anniversary of the vesting date thereafter. 3,827 of those shares are performance restricted stock with a three year cliff vesting on February 7, 2029 if the performance goal is achieved.
2	Common	Common Stock	2026-02-09	S	D	5,056	$49.79	172,147	D	—	—	(F3) Range of reported sale price is $49.38 - $50.27. Reporting person agrees to provide individual transaction information to SEC upon request. (F4) 62,287 shares reported are owned jointly with spouse. (F5) 5,056 shares were withheld and sold through the Company sponsored cashless stock exercise program, to cover the tax liability for vesting a total of 11,265 shares.
3	Common	Common Stock	2026-02-09	A	A	1,516	$0.00	177,203	D	—	—	(F2) 1,516 shares were granted and vested on February 9, 2026. These shares were related to 2023 and 2024 additional performance shares.